These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25916051)

  • 1. Lymph node ratio may predict relapse free survival and overall survival in patients with stage II & III colorectal carcinoma.
    Zekri J; Ahmad I; Fawzy E; Elkhodary TR; Al-Gahmi A; Hassouna A; El Sayed ME; Ur Rehman J; Karim SM; Bin Sadiq B
    Hepatogastroenterology; 2015; 62(138):291-4. PubMed ID: 25916051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrathoracic lymph node ratio seems to be a better prognostic factor than the level of lymph node involvement in lung metastasectomy of colorectal carcinoma.
    Renaud S; Falcoz PE; Olland A; Schaeffer M; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):215-21. PubMed ID: 25358477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lymph node ratio in stage III colorectal cancer.
    Wong KP; Poon JT; Fan JK; Law WL
    Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of metastatic lymph nodes is more important for rectal cancer patients treated with preoperative chemoradiotherapy.
    Park IJ; Yu CS; Lim SB; Yoon YS; Kim CW; Kim TW; Kim JH; Kim JC
    World J Gastroenterol; 2015 Mar; 21(11):3274-81. PubMed ID: 25805934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
    Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
    J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.
    Jiang K; Zhu Y; Liu Y; Ye Y; Xie Q; Yang X; Wang S
    Tumour Biol; 2014 Nov; 35(11):11685-90. PubMed ID: 25139098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic lymph node ratio and outcome of surgical patients with stage III colorectal cancer].
    Liang J; Wei Y; Zhao C; Hong C
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1663-6. PubMed ID: 23174600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic lymphs nodes and lymph node ratio as predictive factors of survival in perforated and non-perforated T4 colorectal tumors.
    Rodríguez-González D; Martínez-Riera A; Delgado-Plasencia L; Bravo-Gutiérrez A; Alvarez-Argüelles H; Salido E; Fernández-Peralta AM; González-Aguilera JJ; Alarcó-Hernández A; Medina-Arana V
    J Surg Oncol; 2013 Sep; 108(3):176-81. PubMed ID: 23832524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
    Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
    Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
    Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P
    Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study.
    Dings PJ; Elferink MA; Strobbe LJ; de Wilt JH
    Ann Surg Oncol; 2013 Aug; 20(8):2607-14. PubMed ID: 23536053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study.
    Mansouri H; Zemni I; Sakhri S; Ayadi MA; Boujelbene N; Ben Dhiab T
    Womens Health (Lond); 2024; 20():17455057241285396. PubMed ID: 39340307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
    Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
    Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.